News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Marcela V Maus will discuss “Driving New CAR T Cells” in a plenary session on Innovative Technologies at the AACR 2025
AACR/X
Apr 14, 2025, 07:12

Marcela V Maus will discuss “Driving New CAR T Cells” in a plenary session on Innovative Technologies at the AACR 2025

AACR shared a post on X:

“Marcela V Maus will discuss “Driving New CAR T Cells” in a plenary session on Innovative Technologies (Monday, April 28) at the AACR Annual Meeting 2025. Learn more.”

AACR AACR 2025 cancer Marcela V. Maus OncoDaily Oncology
Special Coverage
Societies
May 4, 2025, 05:42
PRIME-RT a randomized phase Il trial: Durvalumab with extended neoadjuvant regimens in locally advanced rectal cancer (LARC)
Blog
May 4, 2025, 05:23
Tinatin Alaverdashvili: Proud to be one of the 19 mentees selected for the ESTRO Mentoring Programme
Blog
May 4, 2025, 05:16
Icro Meattini: Landed in Vienna for ESTRO25
Blog
May 4, 2025, 05:10
Amy C. Moore: En route to spend time with friends and colleagues at HOPE Summit25
Blog
May 4, 2025, 05:00
Emil Lou: AACR25 marked the Scientist Survivor Program's 27th year
Insight
May 4, 2025, 04:58
Shaalan Beg highlights Emil Lou’s presentation on CRISPR-Cas9-edited T cells targeting CISH in metastatic colorectal cancer at AACR25
Blog
May 4, 2025, 04:52
EORTC researchers will be presenting cutting-edge findings in radiation oncology at ESTRO25
Blog
May 4, 2025, 04:45
UICC - Capturing Cancer Research and Care in Sweden
Insight
May 4, 2025, 03:18
Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche’s TROP2 diagnostic assay
Blog
May 4, 2025, 03:11
Digestive Cancers Europe: Download My DiCE Companion to monitor your cancer journey
Career
May 4, 2025, 02:53
Narjust Florez: Why run for the IASLC?
Opinion
May 4, 2025, 02:40
Abner Antonio Murray highlights Brooke Felsheim and Charles Perou’s key findings at AACR25 on TNBC prognosis